Back to Trials
NCT06587204NARecruiting

Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health

University of Miami

Start Date

9/15/2025

Completion Date

12/31/2026

Summary

The objective of the UDECIDE study is to demonstrate adherence to decentralized clinical trials among underrepresented groups with cardiometabolic conditions .

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * History of pre-diabetes/diabetes and/or pre-hypertension/hypertension * History of Cardiometabolic risk factors including the following: hypertension, Coronary Artery Disease (CAD), heart attack, heart failure, stroke, atherosclerosis, arrhythmias, Peripheral Artery Disease (PAD), type 2 diabetes, metabolic syndrome, obesity, dyslipidemia, insulin resistance, or elevated cholesterol. * Identify as Black or non-White Hispanic * Own a smart phone Exclusion Criteria: * Does not meet inclusion criteria

Interventions

OTHER

Control Group

BEHAVIORAL

Decentralized Group

BEHAVIORAL

Digital Literacy Navigation Group

BEHAVIORAL

Social Care Navigation Group

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Heart Diseases

Locations

University of Miami

Miami, Florida 33136

United States